Genetic basis of drug-induced liver injury: present and future.
about
Herbal Hepatotoxicity: Clinical Characteristics and Listing CompilationRUCAM in Drug and Herb Induced Liver Injury: The UpdateEnoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS)A universal system to select gene-modified hepatocytes in vivoDrug-induced liver injury: Advances in mechanistic understanding that will inform risk management.Autoimmune-like drug-induced liver injury: a review and update for the clinician.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury.Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.Drug-Induced Liver Injury: Pattern Recognition and Future Directions.Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?Drug-induced liver injury: Do we know everything?Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.Hepatotoxicity of green tea: an update.Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.The pathogenesis of drug-induced liver injury.Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?Human cholestatic hepatitis owing to polyoxyethylene nonylphenol ingestion: A case report."Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model.Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy.Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune Cells.Idiosyncratic drug-induced liver injury: A short review.miR-122-5p as a plasma biomarker of liver injury in fish exposed to microcystin-LR.Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspectiveModels of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives
P2860
Q26748874-5070E0DA-33EA-46F4-A424-EAA3A42B038CQ26771817-C2720EA6-6B2F-431A-A15C-13F89F98A948Q28074812-A615B091-7259-409E-9983-414EAD44C754Q28468539-BE5565CA-B8A2-46D0-BE0C-3039A8A0820BQ30241050-90C46FEF-8489-45C5-A571-C28EFBCF1785Q30276377-C48ED1EB-0947-4B0F-8BE9-9F2789FCF385Q30277969-A4BAD064-625B-4B87-858E-235F1718C9E5Q33775796-E2EABB4D-C87F-409B-915B-6ED546FA9412Q33917967-A2BA55FE-D442-4168-8A75-817DB35E8E78Q35819331-FF0AB277-6004-4CA0-8E94-5265FBAB2476Q36412863-221E86FA-AD95-4259-83AB-27D887817EDBQ36935435-FEEC99D5-32D2-46EC-B981-4C79DB91F566Q37748005-034BEBF5-1FDB-4DAD-AA76-FCD682FCF9D1Q38285818-A6779AE0-608E-42CD-BD4E-1ACBB7DDEAE8Q38391340-47503FF6-DE0F-4B00-B763-B92AB8CD84BDQ38481053-D1A5B70A-8C3E-4BDC-8EF6-020D47094CE1Q38733565-852AD273-5596-446C-AE60-C19B341E377DQ38774776-D466E6CF-20EA-48D3-814B-5BF1736EA07DQ38824550-536AD403-5F90-4244-9620-5A59AB6D8694Q38849978-18078484-F4B0-48EB-97BC-E7C2C81D9DBCQ39043874-F72EA275-0BB7-4C6B-9FDA-C657E86E2D01Q39061191-751E9FB8-49BF-4352-84C8-BCAC6CC59E53Q39158128-6811961E-64DF-41FB-A19E-7F4135EB0849Q40454552-76C9941E-3E2C-47DB-9EEC-81FDB384B78AQ41389082-BAA820C7-3330-43CB-A3D2-9CFE57B033D7Q41390408-7AB54522-4259-464A-B043-E3C72A3BE0F8Q41660660-E9FE7935-B5D9-4A91-BA05-18DF34877EC2Q41747844-3543E6AA-5CC5-4D25-A26D-AA7ACEF7A85AQ47446885-185BF843-1926-47A6-BEC5-5BEAD536F455Q48296572-3B3C3704-9687-406F-A8C2-34F94B850DEDQ50699986-2E0DF1FC-3DDE-4CAA-B0C8-5414142D6FCAQ51770747-E597F6AF-F45A-45CD-855E-D29838A0E581Q53354536-3BFAD22A-0407-4A3D-B179-3F36CCEE4170Q54203690-42D83338-B307-4DD1-B71B-E0BB755D9A4DQ58045340-62F662D7-9B71-43C3-A86D-AAB0E94647E6Q58804131-8433AA3B-D889-4D88-B970-2887D8F4D7B8
P2860
Genetic basis of drug-induced liver injury: present and future.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetic basis of drug-induced liver injury: present and future.
@en
type
label
Genetic basis of drug-induced liver injury: present and future.
@en
prefLabel
Genetic basis of drug-induced liver injury: present and future.
@en
P356
P1476
Genetic basis of drug-induced liver injury: present and future.
@en
P2093
Thomas J Urban
P304
P356
10.1055/S-0034-1375954
P577
2014-05-31T00:00:00Z